4 terminated, 2 active not recruiting. 5 Phase 2, 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Terminated 4, Active not recruiting 1 |
| Phase 1 | 3 | Terminated 2, Active not recruiting 1 |
Follow benzamide: new trials by email Literature Review of benzamide trials Research Report on benzamide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Defactinib and VS-6766 for the Treatment of Patients With Metastatic Uveal Melanoma Defactinib Hydrochloride, Raf/MEK Inhibitor VS-6766, Biopsy - Metastatic Uveal Melanoma | Phase 2 | Terminated | Thomas Jefferson University | 13 | 2021-01-26 | 2025-07-15 |
| Acalabrutinib for the Treatment of Chronic Graft Versus Host Disease Acalabrutinib, Questionnaire Administration - Recurrent Moderate-Severe Chronic Graft Versus Host Disease, Hematopoietic and Lymphoid Cell Neoplasm | Phase 2 | Active not recruiting | Fred Hutchinson Cancer Center | 51 | 2020-12-11 | 2026-10-14 |
| Mocetinostat With Vinorelbine in Children, Adolescents & Young Adults With Refractory and/or Recurrent Rhabdomyosarcoma Vinorelbine, Mocetinostat - Rhabdomyosarcoma | Phase 1 | Active not recruiting | Jonsson Comprehensive Cancer Center | 14 | 2020-05-14 | 2026-07-17 |
| Erdafitinib and Abiraterone Acetate or Enzalutamide in Treating Patients With Double Negative Prostate Cancer Abiraterone Acetate, Enzalutamide, Erdafitinib - Castration-Resistant Prostate Carcinoma, Double-Negative Prostate Carcinoma | Phase 2 | Terminated | University of Washington | 3 | 2020-04-27 | 2023-09-28 |
| Taladegib, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Localized Esophageal or Gastroesophageal Junction Cancer Carboplatin, External Beam Radiation Therapy, Laboratory Biomarker Analysis - Gastroesophageal Junction Adenocarcinoma, Stage IB Esophageal Adenocarcinoma AJCC v7 | Phase 1 / Phase 2 | Terminated | M.D. Anderson Cancer Center | 7 | 2017-03-07 | 2023-07-10 |
| Enzalutamide With Ribociclib in Treating Patients With Metastatic Castrate-Resistant, Chemotherapy Naive Prostate Cancer That Retains Retinoblastoma Expression Enzalutamide, Ribociclib, Laboratory Biomarker Analysis - Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma | Phase 1 / Phase 2 | Terminated | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 52 | 2015-12-01 | 2026-04-22 |
Prostatic Neoplasms (2) · Adenocarcinoma Of Esophagus (1) · Hematologic Neoplasms (1) · Rhabdomyosarcoma (1) · Uveal Melanoma (1)
Fred Hutchinson Cancer Center (1) · Jonsson Comprehensive Cancer Center (1) · M.D. Anderson Cancer Center (1) · Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University (1) · Thomas Jefferson University (1) · University of Washington (1)
United States (6)
Jaffer A Ajani (1) · Michael Schweizer (1) · Noah C. Federman, MD (1) · Rino Seedor, MD (1) · Stephanie Lee, MD, MPH (1) · William Kevin Kelly, MD (1)